Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)

Affiliation auteurs!!!! Error affiliation !!!!
TitreHealth-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
Type de publicationJournal Article
Year of Publication2021
AuteursSmith M.R, Sandhu S.K, George D.J, Chi K.N, Saad F., Thiery-Vuillemin A., Stahl O., Olmos D., Danila D., Gafanov R., Castro E., Moon H., Joshua A.M, Mason G.E, Espina B.M, Liu Y., Bevans K.B, Lopez-Gitlitz A., Francis P., Fizazi K.
JournalANNALS OF ONCOLOGY
Volume32
PaginationS632-S633
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2021.08.1095